{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:13:34Z","timestamp":1784045614099,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD), is one of the main liver diseases in the US and the world which often is related to obesity. Previously, we reported short- and long-term consumption of soy protein isolate diet with high isoflavones can reduce liver steatosis in the male and female obese Zucker rat model. However, the effects of high vs. low soy isoflavones on NAFLD is less known. The objectives of the present study were to examine the role of isoflavones levels in soy protein concentrate diets on protection against NAFLD in an obese rat model. Forty-two 6-week old lean (L, <jats:italic>n<\/jats:italic> = 21) and obese (O, <jats:italic>n<\/jats:italic> = 21) Zucker rats were randomly assigned to 1 of 3 dietary groups: casein diet (C = control), soy protein concentrate with low isoflavones (LIF), or soy protein concentrate with high isoflavones (HIF) for 9 weeks. Rats were weighed twice weekly. After 9 weeks, rats were sacrificed and samples of livers were taken for histopathological analysis. Serums were collected to measure ALT and AST levels. Results indicate that obese rats gained significantly more weight than lean rats for all three diet groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). No significant difference in body weight between LC, LLIF and LHIF was noted. However, the OLIF and OHIF rats gained significantly more weight than OC rats (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Liver steatosis scores were significantly greater in obese rats compared to lean rats (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The OLIF and OHIF-fed rats had significantly reduced steatosis scores than OC rats (<jats:italic>P<\/jats:italic> = 0.013 and <jats:italic>P<\/jats:italic> &amp;lt; 0.001, respectively). The serum ALT levels were significantly greater in OC, OLIF and OHIF compared to LC, LLIF and LHIF, respectively (<jats:italic>P<\/jats:italic> &amp;lt; 0.001, <jats:italic>P<\/jats:italic> &amp;lt; 0.001, and <jats:italic>P<\/jats:italic> = 0.011). AST serum levels were greater in OC and OLIF compared to LC and LLIF, respectively (<jats:italic>P<\/jats:italic> = 0.001 and <jats:italic>P<\/jats:italic> = 0.022). In summary, we found that soy protein concentrate with isoflavones protects against liver steatosis and the protection is greater with a higher concentration of isoflavones.<\/jats:p>","DOI":"10.3389\/fnut.2022.913571","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T16:40:52Z","timestamp":1655916052000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats"],"prefix":"10.3389","volume":"9","author":[{"given":"Reza","family":"Hakkak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Spray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"B\u00f8rsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Korourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"B1","unstructured":"Center for Disease Control and Prevention Website"},{"key":"B2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/ijerph14040435","article-title":"Economic burden of obesity: a systematic literature review","volume":"14","author":"Tremmel","year":"2017","journal-title":"Int J Environ Res Public Health."},{"key":"B3","first-page":"S176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am J Manag Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"Epidemiology: nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","article-title":"NAFLD \u2014 sounding the alarm on a silent epidemic","volume":"17","author":"Lazarus","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/hep.31533","article-title":"Tackling nonalcoholic fatty liver disease: three targeted populations","volume":"73","author":"Wegermann","year":"2021","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1515\/jpem-2019-0403","article-title":"Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity","volume":"33","author":"Mohamed","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1533\/9781845696078.237","article-title":"Soy food products and their health benefits","author":"Guo","year":"2009","journal-title":"Funct Foods"},{"key":"B11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1056\/NEJM199508033330502","article-title":"Meta-analysis of the effects of soy protein intake on serum lipids","volume":"333","author":"Anderson","year":"1995","journal-title":"NEJM."},{"key":"B12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/jn\/134.3.522","article-title":"Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats","volume":"134","author":"Ascencio","year":"2004","journal-title":"J Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/jn\/132.9.2562","article-title":"soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome","volume":"132","author":"Tovar","year":"2002","journal-title":"J Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/ajcn.81.2.397","article-title":"Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile","volume":"81","author":"Zhan","year":"2005","journal-title":"Am J Clin Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2302S","DOI":"10.3945\/jn.110.124958","article-title":"Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms","volume":"140","author":"Jenkins","year":"2010","journal-title":"J Nutr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1079\/BJN20061837","article-title":"Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats","volume":"96","author":"Gudbrandsen","year":"2006","journal-title":"Br J Nutr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12263-012-0294-6","article-title":"Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors","volume":"7","author":"Hakkak","year":"2012","journal-title":"Genes Nutr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1089\/jmf.2015.0002","article-title":"Short- and long-term soy diet versus casein protects liver steatosis independent of the arginine content","volume":"18","author":"Hakkak","year":"2015","journal-title":"J Med Food"},{"key":"B19","doi-asserted-by":"publisher","first-page":"pii:E55","DOI":"10.3390\/biomedicines6020055","article-title":"Short-term soy protein isolate feeding prevents liver steatosis and reduces serum ALT and AST levels in obese female Zucker rats","volume":"6","author":"Hakkak","year":"2018","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/ol.2010.202","article-title":"Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development","volume":"2","author":"Hakkak","year":"2011","journal-title":"Oncol Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1055\/s-0031-1287855","article-title":"Soy protein isolate modified metabolic phenotype and hepatic Wnt signaling in obese Zucker rats","volume":"43","author":"Cain","year":"2011","journal-title":"Horm Metab Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/jn\/133.5.1238","article-title":"Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264. 7 cells","volume":"133","author":"Mezei","year":"2003","journal-title":"J Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbalip.2013.08.018","article-title":"Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle","volume":"1841","author":"Palacios-Gonz\u00e1lez","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1194\/jlr.M500067-JLR200","article-title":"Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa\/fa rats","volume":"46","author":"Tovar","year":"2005","journal-title":"J Lipid Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/toxsci\/47.1.110","article-title":"Diet and risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats","volume":"47","author":"Korourian","year":"1999","journal-title":"Toxicol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1017\/S0007114509990729","article-title":"Experimental rat models to study the metabolic syndrome","volume":"102","author":"Aleixandre De Arti\u00f1ano","year":"2009","journal-title":"Br J Nutr"},{"key":"B30","first-page":"148","article-title":"The zucker fatty rat: a review","volume":"36","author":"Bray","year":"1977","journal-title":"Fed Proc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"699620","DOI":"10.3389\/fnut.2021.699620","article-title":"Effects of short and long-term soy protein isolate intake on hepatic cytochrome p450 expression in obese zucker rats","volume":"8","author":"Kozaczek","year":"2021","journal-title":"Front Nutr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nut.2008.10.020","article-title":"A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats","volume":"25","author":"Gudbrandsen","year":"2009","journal-title":"Nutrition"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/jf001198+","article-title":"Suppression effect of soy isoflavones on nitric oxide production in RAW 264. 7 macrophages","volume":"49","author":"Sheu","year":"2001","journal-title":"J Agric Food Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/sj.bjp.0706075","article-title":"The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro","volume":"144","author":"R\u00e4thel","year":"2005","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1079\/BJN20051496","article-title":"Dietary proteins with high isoflavone content or low methionineglycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa\/fa rats","volume":"94","author":"Gudbrandsen","year":"2005","journal-title":"Br J Nutr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3164\/jcbn.16-98","article-title":"Effects of soy isoflavone on hepatic steatosis in high fat-induced ats","volume":"61","author":"Liu","year":"2017","journal-title":"J Clin Biochem Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ejcn.2014.23","article-title":"Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone diadzein","volume":"68","author":"Frankenfeld","year":"2014","journal-title":"Eur J Clin Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1039\/C6FO01772J","article-title":"A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese zucker rat model","volume":"8","author":"Bell","year":"2017","journal-title":"Food Funct."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/ijo.2010.256","article-title":"Daidzein supplementation prevents nonalcoholic fatty liver disease though alternation of hepatic gene expression profiles and adipocyte metabolism","volume":"35","author":"Kim","year":"2011","journal-title":"Int J Obes."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1210\/jc.2013-1180","article-title":"Genistein in the metabolic syndrome: results of a randomized clinical trial","volume":"98","author":"Squadrito","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2581","DOI":"10.1097\/MD.0000000000025817","article-title":"Soy diet for nonalcoholic liver diseases","volume":"100","author":"Pian Xiong","year":"2021","journal-title":"Medicine"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.913571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T16:40:57Z","timestamp":1655916057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.913571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":41,"alternative-id":["10.3389\/fnut.2022.913571"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.913571","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"article-number":"913571"}}